Riboswitch: Difference between revisions
imported>Kfferty →Engineered riboswitches: Citation added |
imported>IllimarRekand fix disambiguation |
||
| Line 1: | Line 1: | ||
[[File:Lys ribosw 1.jpg|thumb|A 3D representation of the lysine riboswitch]] | {{Short description|Part of a messenger RNA molecule}} | ||
[[File:Lys ribosw 1.jpg|thumb|A 3D representation of the lysine riboswitch ([[Protein Data Bank|PDB]] code:3DIL, orange and blue tubes) bound to lysine (shown as grey, red and blue spheres in the upper middle of the structure)]] | |||
In [[molecular biology]], a '''riboswitch''' is a regulatory segment of a [[messenger RNA]] molecule that binds a [[small molecule]], resulting in a change in [[Translation (biology)|production]] of the [[protein]]s encoded by the mRNA.<ref name="pmid14729327">{{cite journal | vauthors = Nudler E, Mironov AS | title = The riboswitch control of bacterial metabolism | journal = Trends in Biochemical Sciences | volume = 29 | issue = 1 | pages = 11–17 | date = January 2004 | pmid = 14729327 | doi = 10.1016/j.tibs.2003.11.004 }}</ref><ref name="pmid15919195 ">{{cite journal | vauthors = Tucker BJ, Breaker RR | title = Riboswitches as versatile gene control elements | journal = Current Opinion in Structural Biology | volume = 15 | issue = 3 | pages = 342–348 | date = June 2005 | pmid = 15919195 | doi = 10.1016/j.sbi.2005.05.003 }}</ref><ref name="pmid14698618">{{cite journal | vauthors = Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS | title = Riboswitches: the oldest mechanism for the regulation of gene expression? | journal = Trends in Genetics | volume = 20 | issue = 1 | pages = 44–50 | date = January 2004 | pmid = 14698618 | doi = 10.1016/j.tig.2003.11.008 | citeseerx = 10.1.1.312.9100 }}</ref><ref name="pmid16707260">{{cite journal | vauthors = Batey RT | title = Structures of regulatory elements in mRNAs | journal = Current Opinion in Structural Biology | volume = 16 | issue = 3 | pages = 299–306 | date = June 2006 | pmid = 16707260 | doi = 10.1016/j.sbi.2006.05.001 }}</ref> Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its [[Effector (biology)|effector]] molecule. The discovery that modern organisms use RNA to bind small molecules, and discriminate against closely related analogs, expanded the known natural capabilities of RNA beyond its ability to code for [[protein]]s, [[ribozyme|catalyze reactions]], or to bind other RNA or protein [[macromolecule]]s. | In [[molecular biology]], a '''riboswitch''' is a regulatory segment of a [[messenger RNA]] molecule that binds a [[small molecule]], resulting in a change in [[Translation (biology)|production]] of the [[protein]]s encoded by the mRNA.<ref name="pmid14729327">{{cite journal | vauthors = Nudler E, Mironov AS | title = The riboswitch control of bacterial metabolism | journal = Trends in Biochemical Sciences | volume = 29 | issue = 1 | pages = 11–17 | date = January 2004 | pmid = 14729327 | doi = 10.1016/j.tibs.2003.11.004 }}</ref><ref name="pmid15919195 ">{{cite journal | vauthors = Tucker BJ, Breaker RR | title = Riboswitches as versatile gene control elements | journal = Current Opinion in Structural Biology | volume = 15 | issue = 3 | pages = 342–348 | date = June 2005 | pmid = 15919195 | doi = 10.1016/j.sbi.2005.05.003 }}</ref><ref name="pmid14698618">{{cite journal | vauthors = Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS | title = Riboswitches: the oldest mechanism for the regulation of gene expression? | journal = Trends in Genetics | volume = 20 | issue = 1 | pages = 44–50 | date = January 2004 | pmid = 14698618 | doi = 10.1016/j.tig.2003.11.008 | citeseerx = 10.1.1.312.9100 }}</ref><ref name="pmid16707260">{{cite journal | vauthors = Batey RT | title = Structures of regulatory elements in mRNAs | journal = Current Opinion in Structural Biology | volume = 16 | issue = 3 | pages = 299–306 | date = June 2006 | pmid = 16707260 | doi = 10.1016/j.sbi.2006.05.001 }}</ref> Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its [[Effector (biology)|effector]] molecule. The discovery that modern organisms use RNA to bind small molecules, and discriminate against closely related analogs, expanded the known natural capabilities of RNA beyond its ability to code for [[protein]]s, [[ribozyme|catalyze reactions]], or to bind other RNA or protein [[macromolecule]]s. | ||
| Line 57: | Line 58: | ||
| titlestyle = background:#e7dcc3 | | titlestyle = background:#e7dcc3 | ||
| state = autocollapse | | state = autocollapse | ||
| list1 | | list1 = {{Gallery | ||
| Image:RF00174.jpg|'''Cobalamin riboswitch''': | | Image:RF00174.jpg|'''Cobalamin riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00174 RF00174]. | ||
| Image:Cyclic di-GMP riboswitch secondary structure.jpg|'''Cyclic di-GMP-I riboswitch''': | | Image:Cyclic di-GMP riboswitch secondary structure.jpg|'''Cyclic di-GMP-I riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF01051 RF01051]. | ||
| Image:C-di-GMP-II-update.svg|'''Cyclic di-GMP-II riboswitch''': | | Image:C-di-GMP-II-update.svg|'''Cyclic di-GMP-II riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. | ||
| Image:RF00050.jpg|'''FMN riboswitch''': | | Image:RF00050.jpg|'''FMN riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00050 RF00050]. | ||
| Image:GlmS ribozyme secondary structure.jpg|'''GlmS ribozyme''': | | Image:GlmS ribozyme secondary structure.jpg|'''GlmS ribozyme''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00234 RF00234]. | ||
| Image:RF00504.jpg|'''Glycine riboswitch''': | | Image:RF00504.jpg|'''Glycine riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00504 RF00504]. | ||
| Image:RF00168.jpg|'''Lysine riboswitch''': | | Image:RF00168.jpg|'''Lysine riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00168 RF00168]. | ||
| Image:RF00522.jpg|'''PreQ1 riboswitch''': | | Image:RF00522.jpg|'''PreQ1 riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00522 RF00522]. | ||
| Image:PreQ1-II.svg|'''PreQ1-II riboswitch''': | | Image:PreQ1-II.svg|'''PreQ1-II riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF01054 RF01054]. | ||
| Image:RF00167.jpg|'''Purine riboswitch''': | | Image:RF00167.jpg|'''Purine riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00167 RF00167]. | ||
| Image:RF00162.jpg|'''SAM riboswitch''': | | Image:RF00162.jpg|'''SAM riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00162 RF00162]. | ||
| Image:RF00521.jpg|'''SAM-II riboswitch''': | | Image:RF00521.jpg|'''SAM-II riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00521 RF00521]. | ||
| Image:SMK riboswitch structure.jpg|'''SAM-III riboswitch (S<sub>MK</sub>)''': | | Image:SMK riboswitch structure.jpg|'''SAM-III riboswitch (S<sub>MK</sub>)''': Secondary structure for the riboswitch marked up by sequence conservation. | ||
| Image:SAM-IV_secondary_structure.jpg|'''SAM-IV riboswitch''': | | Image:SAM-IV_secondary_structure.jpg|'''SAM-IV riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00634 RF00634]. | ||
| Image:SAM-V SScon.png|'''SAM-V riboswitch''': | | Image:SAM-V SScon.png|'''SAM-V riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. | ||
| Image:SAM-SAH-riboswitch.svg|'''SAM-SAH riboswitch''': | | Image:SAM-SAH-riboswitch.svg|'''SAM-SAH riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. | ||
| Image:SAH-riboswitch.svg|'''SAH riboswitch''': | | Image:SAH-riboswitch.svg|'''SAH riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF01057 RF01057]. | ||
| Image:RF00059.jpg|'''TPP riboswitch''': | | Image:RF00059.jpg|'''TPP riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00059 RF00059]. | ||
| Image:THF-riboswitch.svg|'''Tetrahydrofolate riboswitch''': | | Image:THF-riboswitch.svg|'''Tetrahydrofolate riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. | ||
| Image:RF00380.jpg|'''YkoK leader''': | | Image:RF00380.jpg|'''YkoK leader''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF00380 RF00380]. | ||
| Image:Moco riboswitch.svg|'''Moco riboswitch''': | | Image:Moco riboswitch.svg|'''Moco riboswitch''': Secondary structure for the riboswitch marked up by sequence conservation. Family [http://rfam.xfam.org/family/RF01055 RF01055]. | ||
|}} | |}} | ||
}} | }} | ||
| Line 86: | Line 87: | ||
==Computational models== | ==Computational models== | ||
Riboswitches have been also investigated using in-silico approaches.<ref name="PMID19381548">{{cite book |series=Methods in Molecular Biology |year= 2009 |volume=540 |pages=1–13 |doi= 10.1007/978-1-59745-558-9_1 |author=Barrick JE |chapter= Predicting Riboswitch Regulation on a Genomic Scale |title= Riboswitches |pmid=19381548 |isbn= 978-1-934115-88-6 }}</ref><ref name="PMID20061789">{{cite journal | vauthors = Barash D, Gabdank I | title = Energy minimization applied to riboswitches: a perspective and challenges | journal = RNA Biology | volume = 7 | issue = 1 | pages = 90–97 | date = January 2010 | pmid = 20061789 | doi = 10.4161/rna.7.1.10657 | doi-access = free }}</ref><ref name="comp_methods">{{cite book|last1=Chen|first1=Shi-Jie|last2=Burke|first2=Donald H|last3=Adamiak|first3=R W|title=Computational methods for understanding riboswitches / Methods in Enzymology, vol 553|date=2015|publisher=Academic Press|isbn=978-0-12-801618-3|url=http://www.sciencedirect.com/science/bookseries/00766879/553}}</ref> In particular, solutions for riboswitch prediction can be divided into two wide categories: | Riboswitches have been also investigated using in-silico approaches. <ref name="PMID19381548">{{cite book |series=Methods in Molecular Biology |year= 2009 |volume=540 |pages=1–13 |doi= 10.1007/978-1-59745-558-9_1 |author=Barrick JE |chapter= Predicting Riboswitch Regulation on a Genomic Scale |title= Riboswitches |pmid=19381548 |isbn= 978-1-934115-88-6 }}</ref><ref name="PMID20061789">{{cite journal | vauthors = Barash D, Gabdank I | title = Energy minimization applied to riboswitches: a perspective and challenges | journal = RNA Biology | volume = 7 | issue = 1 | pages = 90–97 | date = January 2010 | pmid = 20061789 | doi = 10.4161/rna.7.1.10657 | doi-access = free }}</ref><ref name="comp_methods">{{cite book|last1=Chen|first1=Shi-Jie|last2=Burke|first2=Donald H|last3=Adamiak|first3=R W|title=Computational methods for understanding riboswitches / Methods in Enzymology, vol 553|date=2015|publisher=Academic Press|isbn=978-0-12-801618-3|url=http://www.sciencedirect.com/science/bookseries/00766879/553}}</ref> In particular, solutions for riboswitch prediction can be divided into two wide categories: | ||
* ''riboswitch gene finders'', i.e. systems aimed at uncovering riboswitches by genomic inspections, mostly based on motif-searching mechanisms. This group contains Infernal, the founding component of the [[Rfam]] database,<ref name="PMID19307242">{{cite journal | vauthors = Nawrocki EP, Kolbe DL, Eddy SR | title = Infernal 1.0: inference of RNA alignments | journal = Bioinformatics | volume = 25 | issue = 10 | pages = 1335–1337 | date = May 2009 | pmid = 19307242 | pmc = 2732312 | doi = 10.1093/bioinformatics/btp157 }}</ref> and more specific tools such as RibEx<ref name="PMID15980564">{{cite journal | vauthors = Abreu-Goodger C, Merino E | title = RibEx: a web server for locating riboswitches and other conserved bacterial regulatory elements | journal = Nucleic Acids Research | volume = 33 | issue = Web Server issue | pages = W690-2 | date = July 2005 | pmid = 15980564 | pmc = 1160206 | doi = 10.1093/nar/gki445 }}</ref> or RiboSW.<ref name="PMID19460868">{{cite journal | vauthors = Chang TH, Huang HD, Wu LC, Yeh CT, Liu BJ, Horng JT | title = Computational identification of riboswitches based on RNA conserved functional sequences and conformations | journal = RNA | volume = 15 | issue = 7 | pages = 1426–1430 | date = July 2009 | pmid = 19460868 | pmc = 2704089 | doi = 10.1261/rna.1623809 }}</ref> | * ''riboswitch gene finders'', i.e. systems aimed at uncovering riboswitches by genomic inspections, mostly based on motif-searching mechanisms. This group contains Infernal, the founding component of the [[Rfam]] database,<ref name="PMID19307242">{{cite journal | vauthors = Nawrocki EP, Kolbe DL, Eddy SR | title = Infernal 1.0: inference of RNA alignments | journal = Bioinformatics | volume = 25 | issue = 10 | pages = 1335–1337 | date = May 2009 | pmid = 19307242 | pmc = 2732312 | doi = 10.1093/bioinformatics/btp157 }}</ref> and more specific tools such as RibEx<ref name="PMID15980564">{{cite journal | vauthors = Abreu-Goodger C, Merino E | title = RibEx: a web server for locating riboswitches and other conserved bacterial regulatory elements | journal = Nucleic Acids Research | volume = 33 | issue = Web Server issue | pages = W690-2 | date = July 2005 | pmid = 15980564 | pmc = 1160206 | doi = 10.1093/nar/gki445 }}</ref> or RiboSW.<ref name="PMID19460868">{{cite journal | vauthors = Chang TH, Huang HD, Wu LC, Yeh CT, Liu BJ, Horng JT | title = Computational identification of riboswitches based on RNA conserved functional sequences and conformations | journal = RNA | volume = 15 | issue = 7 | pages = 1426–1430 | date = July 2009 | pmid = 19460868 | pmc = 2704089 | doi = 10.1261/rna.1623809 }}</ref> | ||
* ''conformational switch predictors'', i.e. | * ''conformational switch predictors'', i.e., methods based on a structural classification of alternative structures, such as paRNAss,<ref name="PMID14962925">{{cite journal | vauthors = Voss B, Meyer C, Giegerich R | title = Evaluating the predictability of conformational switching in RNA | journal = Bioinformatics | volume = 20 | issue = 10 | pages = 1573–1582 | date = July 2004 | pmid = 14962925 | doi = 10.1093/bioinformatics/bth129 | doi-access = free }}</ref> RNAshapes<ref name="PMID25273103">{{cite journal | vauthors = Janssen S, Giegerich R | title = The RNA shapes studio | journal = Bioinformatics | volume = 31 | issue = 3 | pages = 423–425 | date = February 2015 | pmid = 25273103 | pmc = 4308662 | doi = 10.1093/bioinformatics/btu649 }}</ref> and RNAbor.<ref name="PMID17573364">{{cite journal | vauthors = Freyhult E, Moulton V, Clote P | title = Boltzmann probability of RNA structural neighbors and riboswitch detection | journal = Bioinformatics | volume = 23 | issue = 16 | pages = 2054–2062 | date = August 2007 | pmid = 17573364 | doi = 10.1093/bioinformatics/btm314 | doi-access = free }}</ref> Moreover, family-specific approaches for ON/OFF structure prediction have been proposed as well.<ref name="PMID22537010">{{cite journal | vauthors = Clote P, Lou F, Lorenz WA | title = Maximum expected accuracy structural neighbors of an RNA secondary structure | journal = BMC Bioinformatics | volume = 13 | issue = Suppl 5 | pages = S6 | date = April 2012 | pmid = 22537010 | pmc = 3358666 | doi = 10.1186/1471-2105-13-S5-S6 | doi-access = free }}</ref> | ||
The SwiSpot tool<ref name="PMID27378291">{{cite journal | vauthors = Barsacchi M, Novoa EM, Kellis M, Bechini A | title = SwiSpot: modeling riboswitches by spotting out switching sequences | journal = Bioinformatics | volume = 32 | issue = 21 | pages = 3252–3259 | date = November 2016 | pmid = 27378291 | doi = 10.1093/bioinformatics/btw401 | doi-access = free | hdl = 11568/817190 | hdl-access = free }}</ref> somehow covers both the groups, as it uses conformational predictions to assess the presence of riboswitches. | The SwiSpot tool<ref name="PMID27378291">{{cite journal | vauthors = Barsacchi M, Novoa EM, Kellis M, Bechini A | title = SwiSpot: modeling riboswitches by spotting out switching sequences | journal = Bioinformatics | volume = 32 | issue = 21 | pages = 3252–3259 | date = November 2016 | pmid = 27378291 | doi = 10.1093/bioinformatics/btw401 | doi-access = free | hdl = 11568/817190 | hdl-access = free }}</ref> somehow covers both the groups, as it uses conformational predictions to assess the presence of riboswitches. | ||
Other computational investigations look into the [[druggability]] properties of riboswitch [[binding sites]], assessing their potency as potential novel drug targets.<ref name= "drugpred_rna">{{Cite journal| doi = 10.1021/acs.jcim.1c00155| issn = 1549-9596| volume = 61| issue = 8| pages = 4068–4081| last1 = Rekand| first1 = Illimar Hugo| last2 = Brenk| first2 = Ruth| title = DrugPred_RNA—A Tool for Structure-Based Druggability Predictions for RNA Binding Sites| journal = Journal of Chemical Information and Modeling| access-date = 2024-03-12| date = 2021-08-23| pmid = 34286972| url = https://doi.org/10.1021/acs.jcim.1c00155}}</ref><ref name ="drlips">{{Cite journal| doi = 10.1093/nar/gkaf239| issn = 1362-4962| volume = 53| issue = 6| pages = 239| last1 = Ramaswamy Krishnan| first1 = Sowmya | last2 = Roy| first2 = Arijit| last3 = Wong| first3 = Limsoon| last4 = Gromiha| first4 = M Michael | title = DRLiPS: a novel method for prediction of druggable RNA-small molecule binding pockets using machine learning| journal = Nucleic Acids Research| access-date = 2025-06-10| date = 2025-04-11| pmid = 40173014| pmc = 11963762| url = https://doi.org/10.1093/nar/gkaf239}}</ref><ref>{{Cite journal| doi = 10.1021/acsmedchemlett.1c00068| volume = 12| issue = 6| pages = 928–934| last1 = Xie| first1 = Jingru| last2 = Frank| first2 = Aaron T.| title = Mining for Ligandable Cavities in RNA| journal = ACS Medicinal Chemistry Letters| access-date = 2025-06-10| date = 2021-06-10| pmid = 34141071| pmc = 8201482| url = https://doi.org/10.1021/acsmedchemlett.1c00068}}</ref> | |||
==The RNA world hypothesis== | ==The RNA world hypothesis== | ||
| Line 98: | Line 101: | ||
==As antibiotic targets== | ==As antibiotic targets== | ||
RNA is already an [[RNA-targeting small molecule drugs|emerging drug target]].<ref name="foo">{{Cite journal| doi = 10.1124/pr.120.019554| issn = 1521-0081| volume = 72| issue = 4| pages = 862–898| last1 = Yu| first1 = Ai-Ming| last2 = Choi| first2 = Young Hee| last3 = Tu| first3 = Mei-Juan| title = RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges| journal = Pharmacological Reviews| date = 2020| pmid = 32929000| pmc = 7495341}}</ref> Multiple factors contribute to riboswitches as targets for novel [[antibiotic]]s: <ref name="panchal">{{Cite journal| doi = 10.3390/antibiotics10010045| volume = 10| issue = 1| pages = 45| last1 = Panchal| first1 = Vipul| last2 = Brenk| first2 = Ruth| title = Riboswitches as Drug Targets for Antibiotics| journal = Antibiotics| date = January 2021| doi-access = free| pmid = 33466288| pmc = 7824784}}</ref><ref>{{Cite journal| doi = 10.1016/j.bmc.2019.04.010| issn = 0968-0896| volume = 27| issue = 11| pages = 2253–2260| last1 = Hewitt| first1 = William M.| last2 = Calabrese| first2 = David R.| last3 = Schneekloth| first3 = John S.| title = Evidence for ligandable sites in structured RNA throughout the Protein Data Bank| journal = Bioorganic & Medicinal Chemistry| date = 2019-06-01| pmid = 30982658| pmc = 8283815}}</ref><ref>{{Cite journal| doi = 10.1021/acs.jcim.1c00155| issn = 1549-9596| volume = 61| issue = 8| pages = 4068–4081| last1 = Rekand| first1 = Illimar Hugo| last2 = Brenk| first2 = Ruth| title = DrugPred_RNA—A Tool for Structure-Based Druggability Predictions for RNA Binding Sites| journal = Journal of Chemical Information and Modeling| access-date = 2024-03-12| date = 2021-08-23| pmid = 34286972| url = https://doi.org/10.1021/acs.jcim.1c00155}}</ref> | |||
* Their ability to bind small molecules with high affinity combined make them suitable for drug targeting | |||
* Some riboswitches contain binding sites that display promising characteristics regarding [[druggability]].<ref>{{Cite journal| doi = 10.4155/fmc-2017-0063| volume = 9| issue = 14| pages = 1649–1662| last1 = Rekand| first1 = Illimar| last2 = Brenk| first2 = Ruth| title = Design of riboswitch ligands, an emerging target class for novel antibiotics| journal = Future Med Chem| date = 2017| pmid = 28925284}}</ref> | |||
* The absence of riboswitches in eukaryotic cells enables them to be highly specific targets for novel antibiotics | |||
* Inhibition of some riboswitches have been proven to be effective in leading to bacterial cell death. | |||
Indeed, some antibiotics whose mechanism of action was unknown for decades have been shown to operate by targeting riboswitches.<ref name="pmid17160062">{{cite journal | vauthors = Blount KF, Breaker RR | title = Riboswitches as antibacterial drug targets | journal = Nature Biotechnology | volume = 24 | issue = 12 | pages = 1558–1564 | date = December 2006 | pmid = 17160062 | doi = 10.1038/nbt1268 | s2cid = 34398395 }}</ref> For example, when the antibiotic [[pyrithiamine]] enters the cell, it is metabolized into pyrithiamine pyrophosphate. Pyrithiamine pyrophosphate has been shown to bind and activate the TPP riboswitch, causing the cell to cease the synthesis and import of TPP. Because pyrithiamine pyrophosphate does not substitute for TPP as a coenzyme, the cell dies. | |||
{{See also|AAC/AAD leader}} | {{See also|AAC/AAD leader}} | ||
| Line 104: | Line 113: | ||
==Engineered riboswitches== | ==Engineered riboswitches== | ||
Since riboswitches are an effective method of controlling gene expression in natural organisms, there has been interest in engineering artificial riboswitches<ref>{{cite journal | vauthors = Bauer G, Suess B | title = Engineered riboswitches as novel tools in molecular biology | journal = Journal of Biotechnology | volume = 124 | issue = 1 | pages = 4–11 | date = June 2006 | pmid = 16442180 | doi = 10.1016/j.jbiotec.2005.12.006 }}</ref><ref>{{cite journal | vauthors = Dixon N, Duncan JN, Geerlings T, Dunstan MS, McCarthy JE, Leys D, Micklefield J | title = Reengineering orthogonally selective riboswitches | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 107 | issue = 7 | pages = 2830–2835 | date = February 2010 | pmid = 20133756 | pmc = 2840279 | doi = 10.1073/pnas.0911209107 | bibcode = 2010PNAS..107.2830D | doi-access = free }}</ref><ref>{{cite journal | vauthors = Verhounig A, Karcher D, Bock R | title = Inducible gene expression from the plastid genome by a synthetic riboswitch | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 107 | issue = 14 | pages = 6204–6209 | date = April 2010 | pmid = 20308585 | pmc = 2852001 | doi = 10.1073/pnas.0914423107 | bibcode = 2010PNAS..107.6204V | doi-access = free }}</ref><ref>{{Citation | | Since riboswitches are an effective method of controlling gene expression in natural organisms, there has been interest in engineering artificial riboswitches<ref>{{cite journal | vauthors = Bauer G, Suess B | title = Engineered riboswitches as novel tools in molecular biology | journal = Journal of Biotechnology | volume = 124 | issue = 1 | pages = 4–11 | date = June 2006 | pmid = 16442180 | doi = 10.1016/j.jbiotec.2005.12.006 }}</ref><ref>{{cite journal | vauthors = Dixon N, Duncan JN, Geerlings T, Dunstan MS, McCarthy JE, Leys D, Micklefield J | title = Reengineering orthogonally selective riboswitches | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 107 | issue = 7 | pages = 2830–2835 | date = February 2010 | pmid = 20133756 | pmc = 2840279 | doi = 10.1073/pnas.0911209107 | bibcode = 2010PNAS..107.2830D | doi-access = free }}</ref><ref>{{cite journal | vauthors = Verhounig A, Karcher D, Bock R | title = Inducible gene expression from the plastid genome by a synthetic riboswitch | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 107 | issue = 14 | pages = 6204–6209 | date = April 2010 | pmid = 20308585 | pmc = 2852001 | doi = 10.1073/pnas.0914423107 | bibcode = 2010PNAS..107.6204V | doi-access = free }}</ref><ref>{{Citation |last1=Fernandez-de-Cossio-Diaz |first1=Jorge |title=Designing Molecular RNA Switches with Restricted Boltzmann Machines |date=2024-04-20 |url=https://www.biorxiv.org/content/10.1101/2023.05.10.540155v2 |access-date=2024-11-10 |language=en |doi=10.1101/2023.05.10.540155 |last2=Hardouin |first2=Pierre |last3=Moutier |first3=Francois-Xavier Lyonnet du |last4=Gioacchino |first4=Andrea Di |last5=Marchand |first5=Bertrand |last6=Ponty |first6=Yann |last7=Sargueil |first7=Bruno |last8=Monasson |first8=Rémi |last9=Cocco |first9=Simona}}</ref> | ||
for industrial and medical applications such as [[gene therapy]].<ref>{{cite journal | vauthors = Ketzer P, Kaufmann JK, Engelhardt S, Bossow S, von Kalle C, Hartig JS, Ungerechts G, Nettelbeck DM | title = Artificial riboswitches for gene expression and replication control of DNA and RNA viruses | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 111 | issue = 5 | pages = E554–562 | date = February 2014 | pmid = 24449891 | pmc = 3918795 | doi = 10.1073/pnas.1318563111 | bibcode = 2014PNAS..111E.554K | doi-access = free }}</ref><ref>{{cite journal | vauthors = Strobel B, Klauser B, Hartig JS, Lamla T, Gantner F, Kreuz S | title = Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells | journal = Molecular Therapy | volume = 23 | issue = 10 | pages = 1582–1591 | date = October 2015 | pmid = 26137851 | pmc = 4817922 | doi = 10.1038/mt.2015.123 }}</ref> | for industrial and medical applications such as [[gene therapy]].<ref>{{cite journal | vauthors = Ketzer P, Kaufmann JK, Engelhardt S, Bossow S, von Kalle C, Hartig JS, Ungerechts G, Nettelbeck DM | title = Artificial riboswitches for gene expression and replication control of DNA and RNA viruses | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 111 | issue = 5 | pages = E554–562 | date = February 2014 | pmid = 24449891 | pmc = 3918795 | doi = 10.1073/pnas.1318563111 | bibcode = 2014PNAS..111E.554K | doi-access = free }}</ref><ref>{{cite journal | vauthors = Strobel B, Klauser B, Hartig JS, Lamla T, Gantner F, Kreuz S | title = Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells | journal = Molecular Therapy | volume = 23 | issue = 10 | pages = 1582–1591 | date = October 2015 | pmid = 26137851 | pmc = 4817922 | doi = 10.1038/mt.2015.123 }}</ref> | ||
Revision as of 13:18, 11 June 2025
In molecular biology, a riboswitch is a regulatory segment of a messenger RNA molecule that binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA.[1][2][3][4] Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its effector molecule. The discovery that modern organisms use RNA to bind small molecules, and discriminate against closely related analogs, expanded the known natural capabilities of RNA beyond its ability to code for proteins, catalyze reactions, or to bind other RNA or protein macromolecules.
The original definition of the term "riboswitch" specified that they directly sense small-molecule metabolite concentrations.[5] Although this definition remains in common use, some biologists have used a broader definition that includes other cis-regulatory RNAs. However, this article will discuss only metabolite-binding riboswitches.
Most known riboswitches occur in bacteria, but functional riboswitches of one type (the TPP riboswitch) have been discovered in archaea, plants and certain fungi. TPP riboswitches have also been predicted in archaea,[6] but have not been experimentally tested.
History and discovery
Prior to the discovery of riboswitches, the mechanism by which some genes involved in multiple metabolic pathways were regulated remained mysterious. Accumulating evidence increasingly suggested the then-unprecedented idea that the mRNAs involved might bind metabolites directly, to affect their own regulation. These data included conserved RNA secondary structures often found in the untranslated regions (UTRs) of the relevant genes and the success of procedures to create artificial small molecule-binding RNAs called aptamers.[7][8][9][10][11] In 2002, the first comprehensive proofs of multiple classes of riboswitches were published, including protein-free binding assays, and metabolite-binding riboswitches were established as a new mechanism of gene regulation.[5][12][13][14]
Many of the earliest riboswitches to be discovered corresponded to conserved sequence "motifs" (patterns) in 5' UTRs that appeared to correspond to a structured RNA. For example, comparative analysis of upstream regions of several genes expected to be co-regulated led to the description of the S-box[15] (now the SAM-I riboswitch), the THI-box[9] (a region within the TPP riboswitch), the RFN element[8] (now the FMN riboswitch) and the B12-box[16] (a part of the cobalamin riboswitch), and in some cases experimental demonstrations that they were involved in gene regulation via an unknown mechanism. Bioinformatics has played a role in more recent discoveries, with increasing automation of the basic comparative genomics strategy. Barrick et al. (2004)[17] used BLAST to find UTRs homologous to all UTRs in Bacillus subtilis. Some of these homologous sets were inspected for conserved structure, resulting in 10 RNA-like motifs. Three of these were later experimentally confirmed as the glmS, glycine and PreQ1-I riboswitches (see below). Subsequent comparative genomics efforts using additional taxa of bacteria and improved computer algorithms have identified further riboswitches that are experimentally confirmed, as well as conserved RNA structures that are hypothesized to function as riboswitches.[18][19][20]
Mechanisms
Riboswitches are often conceptually divided into two parts: an aptamer and an expression platform. The aptamer directly binds the small molecule, and the expression platform undergoes structural changes in response to the changes in the aptamer. The expression platform is what regulates gene expression.
Expression platforms typically turn off gene expression in response to the small molecule, but some turn it on. The following riboswitch mechanisms have been experimentally demonstrated.
- Riboswitch-controlled formation of rho-independent transcription termination hairpins leads to premature transcription termination.
- Riboswitch-mediated folding sequesters the ribosome-binding site, thereby inhibiting translation.
- The riboswitch is a ribozyme that cleaves itself in the presence of sufficient concentrations of its metabolite.
- Riboswitch alternate structures affect the splicing of the pre-mRNA.
- A TPP riboswitch in Neurospora crassa (a fungus) controls alternative splicing to conditionally produce an Upstream Open Reading Frame (uORF), thereby affecting the expression of downstream genes[21]
- A TPP riboswitch in plants modifies splicing and alternative 3'-end processing[22][23]
- A riboswitch in Clostridium acetobutylicum regulates an adjacent gene that is not part of the same mRNA transcript. In this regulation, the riboswitch interferes with transcription of the gene. The mechanism is uncertain but may be caused by clashes between two RNA polymerase units as they simultaneously transcribe the same DNA.[24]
- A riboswitch in Listeria monocytogenes regulates the expression of its downstream gene. However, riboswitch transcripts subsequently modulate the expression of a gene located elsewhere in the genome.[25] This trans regulation occurs via base-pairing to the mRNA of the distal gene. As the temperature of the bacterium increases, the riboswitch melts, allowing transcription. Unpublished undergraduate research created a similar riboswitch or 'thermosensor' via random mutagenesis of the Listeria monocytogenes sequence.[26]
Types
The following is a list of experimentally validated riboswitches, organized by ligand.
- Cobalamin riboswitch (also B12-element), which binds either adenosylcobalamin (the coenzyme form of vitamin B12) or aquocobalamin to regulate cobalamin biosynthesis and transport of cobalamin and similar metabolites, and other genes.
- cyclic AMP-GMP riboswitches bind the signaling molecule cyclic AMP-GMP. These riboswitches are structurally related to cyclic di-GMP-I riboswitches (see also "cyclic di-GMP" below).
- cyclic di-AMP riboswitches (also called ydaO/yuaA) bind the signaling molecule cyclic di-AMP.
- cyclic di-GMP riboswitches bind the signaling molecule cyclic di-GMP in order to regulate a variety of genes controlled by this second messenger. Two classes of cyclic di-GMP riboswitches are known: cyclic di-GMP-I riboswitches and cyclic di-GMP-II riboswitches. These classes do not appear to be structurally related.
- fluoride riboswitches sense fluoride ions, and function in surviving high levels of fluoride.
- FMN riboswitch (also RFN-element) binds flavin mononucleotide (FMN) to regulate riboflavin biosynthesis and transport.
- glmS riboswitch, which is a ribozyme that cleaves itself when there is a sufficient concentration of glucosamine-6-phosphate.
- Glutamine riboswitches bind glutamine to regulate genes involved in glutamine and nitrogen metabolism, as well as short peptides of unknown function. Two classes of glutamine riboswitches are known: the glnA RNA motif and Downstream-peptide motif. These classes are believed to be structurally related (see discussions in those articles).
- Glycine riboswitch binds glycine to regulate glycine metabolism genes, including the use of glycine as an energy source. Previous to 2012, this riboswitch was thought to be the only that exhibits cooperative binding, as it contains contiguous dual aptamers. Though no longer shown to be cooperative, the cause of dual aptamers still remains ambiguous.[27]
- Lysine riboswitch (also L-box) binds lysine to regulate lysine biosynthesis, catabolism and transport.
- manganese riboswitches bind manganese ions.
- NiCo riboswitches bind the metal ions nickel and cobalt.
- PreQ1 riboswitches bind pre-queuosine1, to regulate genes involved in the synthesis or transport of this precursor to queuosine. Three entirely distinct classes of PreQ1 riboswitches are known: PreQ1-I riboswitches, PreQ1-II riboswitches and PreQ1-III riboswitches. The binding domain of PreQ1-I riboswitches are unusually small among naturally occurring riboswitches. PreQ1-II riboswitches, which are only found in certain species in the genera Streptococcus and Lactococcus, have a completely different structure, and are larger, as are PreQ1-III riboswitches.
- Purine riboswitches binds purines to regulate purine metabolism and transport. Different forms of the purine riboswitch bind guanine (a form originally known as the G-box) or adenine. The specificity for either guanine or adenine depends completely upon Watson-Crick interactions with a single pyrimidine in the riboswitch at position Y74. In the guanine riboswitch this residue is always a cytosine (i.e. C74), in the adenine residue it is always a uracil (i.e. U74). Homologous types of purine riboswitches bind deoxyguanosine, but have more significant differences than a single nucleotide mutation.
- SAH riboswitches bind S-adenosylhomocysteine to regulate genes involved in recycling this metabolite that is produced when S-adenosylmethionine is used in methylation reactions.
- SAM riboswitches bind S-adenosyl methionine (SAM) to regulate methionine and SAM biosynthesis and transport. Three distinct SAM riboswitches are known: SAM-I (originally called S-box), SAM-II and the SMK box riboswitch. SAM-I is widespread in bacteria, but SAM-II is found only in Alpha-, Beta-, and a few Gammaproteobacteria. The SMK box riboswitch is found only in the order Lactobacillales. These three varieties of riboswitch have no obvious similarities in terms of sequence or structure. A fourth variety, SAM-IV riboswitches, appears to have a similar ligand-binding core to that of SAM-I riboswitches, but in the context of a distinct scaffold.
- SAM-SAH riboswitches bind both SAM and SAH with similar affinities. Since they are always found in a position to regulate genes encoding methionine adenosyltransferase, it was proposed that only their binding to SAM is physiologically relevant.
- Tetrahydrofolate riboswitches bind tetrahydrofolate to regulate synthesis and transport genes.
- TPP riboswitches (also THI-box) binds thiamin pyrophosphate (TPP) to regulate thiamin biosynthesis and transport, as well as transport of similar metabolites. It is the only riboswitch found so far in eukaryotes.[28]
- ZMP/ZTP riboswitches sense ZMP and ZTP, which are by-products of de novo purine metabolism when levels of 10-Formyltetrahydrofolate are low.
Presumed riboswitches:
- Moco RNA motif is presumed to bind molybdenum cofactor, to regulate genes involved in biosynthesis and transport of this coenzyme, as well as enzymes that use it or its derivatives as a cofactor.
Script error: No such module "Navbox".
Candidate metabolite-binding riboswitches have been identified using bioinformatics, and have moderately complex secondary structures and several highly conserved nucleotide positions, as these features are typical of riboswitches that must specifically bind a small molecule. Riboswitch candidates are also consistently located in the 5' UTRs of protein-coding genes, and these genes are suggestive of metabolite binding, as these are also features of most known riboswitches. Hypothesized riboswitch candidates highly consistent with the preceding criteria are as follows: crcB RNA Motif, manA RNA motif, pfl RNA motif, ydaO/yuaA leader, yjdF RNA motif, ykkC-yxkD leader (and related ykkC-III RNA motif) and the yybP-ykoY leader. The functions of these hypothetical riboswitches remain unknown.
Computational models
Riboswitches have been also investigated using in-silico approaches. [29][30][31] In particular, solutions for riboswitch prediction can be divided into two wide categories:
- riboswitch gene finders, i.e. systems aimed at uncovering riboswitches by genomic inspections, mostly based on motif-searching mechanisms. This group contains Infernal, the founding component of the Rfam database,[32] and more specific tools such as RibEx[33] or RiboSW.[34]
- conformational switch predictors, i.e., methods based on a structural classification of alternative structures, such as paRNAss,[35] RNAshapes[36] and RNAbor.[37] Moreover, family-specific approaches for ON/OFF structure prediction have been proposed as well.[38]
The SwiSpot tool[39] somehow covers both the groups, as it uses conformational predictions to assess the presence of riboswitches.
Other computational investigations look into the druggability properties of riboswitch binding sites, assessing their potency as potential novel drug targets.[40][41][42]
The RNA world hypothesis
Riboswitches demonstrate that naturally occurring RNA can bind small molecules specifically, a capability that many previously believed was the domain of proteins or artificially constructed RNAs called aptamers. The existence of riboswitches in all domains of life therefore adds some support to the RNA world hypothesis, which holds that life originally existed using only RNA, and proteins came later; this hypothesis requires that all critical functions performed by proteins (including small molecule binding) could be performed by RNA. It has been suggested that some riboswitches might represent ancient regulatory systems, or even remnants of RNA-world ribozymes whose bindings domains are conserved.[13][18][43]
As antibiotic targets
RNA is already an emerging drug target.[44] Multiple factors contribute to riboswitches as targets for novel antibiotics: [45][46][47]
- Their ability to bind small molecules with high affinity combined make them suitable for drug targeting
- Some riboswitches contain binding sites that display promising characteristics regarding druggability.[48]
- The absence of riboswitches in eukaryotic cells enables them to be highly specific targets for novel antibiotics
- Inhibition of some riboswitches have been proven to be effective in leading to bacterial cell death.
Indeed, some antibiotics whose mechanism of action was unknown for decades have been shown to operate by targeting riboswitches.[49] For example, when the antibiotic pyrithiamine enters the cell, it is metabolized into pyrithiamine pyrophosphate. Pyrithiamine pyrophosphate has been shown to bind and activate the TPP riboswitch, causing the cell to cease the synthesis and import of TPP. Because pyrithiamine pyrophosphate does not substitute for TPP as a coenzyme, the cell dies.
Script error: No such module "Labelled list hatnote".
Engineered riboswitches
Since riboswitches are an effective method of controlling gene expression in natural organisms, there has been interest in engineering artificial riboswitches[50][51][52][53] for industrial and medical applications such as gene therapy.[54][55]
See also
- RNA thermometer - Another class of mRNA regulatory segments which change conformation in response to temperature fluctuations, thereby exposing or occluding the ribosome binding site.
References
Further reading
- Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".